nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—SLCO2B1—Erlotinib—kidney cancer	0.158	0.364	CbGbCtD
Niacin—SLC22A5—Dactinomycin—kidney cancer	0.118	0.272	CbGbCtD
Niacin—CYP2D6—Temsirolimus—kidney cancer	0.0589	0.135	CbGbCtD
Niacin—CYP2D6—Pazopanib—kidney cancer	0.031	0.0711	CbGbCtD
Niacin—CYP2D6—Erlotinib—kidney cancer	0.0221	0.0508	CbGbCtD
Niacin—CYP2D6—Sorafenib—kidney cancer	0.018	0.0413	CbGbCtD
Niacin—CYP2D6—Vinblastine—kidney cancer	0.0177	0.0408	CbGbCtD
Niacin—CYP2D6—Doxorubicin—kidney cancer	0.0109	0.025	CbGbCtD
Niacin—QPRT—renal system—kidney cancer	0.0107	0.132	CbGeAlD
Niacin—QPRT—kidney—kidney cancer	0.0104	0.128	CbGeAlD
Niacin—NNMT—nephron tubule—kidney cancer	0.00556	0.0686	CbGeAlD
Niacin—NNMT—renal system—kidney cancer	0.00505	0.0624	CbGeAlD
Niacin—NNMT—kidney—kidney cancer	0.00488	0.0603	CbGeAlD
Niacin—NNMT—cortex of kidney—kidney cancer	0.00476	0.0588	CbGeAlD
Niacin—NNMT—cardiac atrium—kidney cancer	0.00452	0.0559	CbGeAlD
Niacin—SLC16A3—renal system—kidney cancer	0.00345	0.0426	CbGeAlD
Niacin—SLC16A3—kidney—kidney cancer	0.00334	0.0412	CbGeAlD
Niacin—SLC16A3—cortex of kidney—kidney cancer	0.00325	0.0401	CbGeAlD
Niacin—CYP2D6—urine—kidney cancer	0.00316	0.039	CbGeAlD
Niacin—SLC16A3—gonad—kidney cancer	0.00309	0.0382	CbGeAlD
Niacin—SLC22A5—Temsirolimus—Everolimus—kidney cancer	0.00308	0.549	CbGdCrCtD
Niacin—SLC16A3—Azacitidine—Gemcitabine—kidney cancer	0.00253	0.451	CbGdCrCtD
Niacin—SLC16A1—renal system—kidney cancer	0.0021	0.0259	CbGeAlD
Niacin—SLC16A1—kidney—kidney cancer	0.00203	0.025	CbGeAlD
Niacin—SLC16A1—gonad—kidney cancer	0.00188	0.0232	CbGeAlD
Niacin—SLC16A1—cardiac atrium—kidney cancer	0.00188	0.0232	CbGeAlD
Niacin—SLCO2B1—renal system—kidney cancer	0.0018	0.0223	CbGeAlD
Niacin—SLCO2B1—kidney—kidney cancer	0.00174	0.0215	CbGeAlD
Niacin—SLC22A5—nephron tubule—kidney cancer	0.00132	0.0163	CbGeAlD
Niacin—SLC22A5—renal system—kidney cancer	0.0012	0.0148	CbGeAlD
Niacin—SLC22A5—kidney—kidney cancer	0.00116	0.0143	CbGeAlD
Niacin—SLC22A5—cortex of kidney—kidney cancer	0.00113	0.0139	CbGeAlD
Niacin—SLC22A5—cardiac atrium—kidney cancer	0.00107	0.0132	CbGeAlD
Niacin—Salicylic acid—PTGS1—kidney cancer	0.000832	0.486	CrCbGaD
Niacin—CYP2D6—renal system—kidney cancer	0.000773	0.00955	CbGeAlD
Niacin—CYP2D6—kidney—kidney cancer	0.000747	0.00923	CbGeAlD
Niacin—Salicylic acid—PTGS2—kidney cancer	0.000476	0.278	CrCbGaD
Niacin—Salicylic acid—ABCB1—kidney cancer	0.000404	0.236	CrCbGaD
Niacin—Insomnia—Vincristine—kidney cancer	0.000171	0.000556	CcSEcCtD
Niacin—Anorexia—Gemcitabine—kidney cancer	0.000171	0.000555	CcSEcCtD
Niacin—Oedema peripheral—Capecitabine—kidney cancer	0.000171	0.000555	CcSEcCtD
Niacin—Vomiting—Vinblastine—kidney cancer	0.000171	0.000555	CcSEcCtD
Niacin—Dizziness—Erlotinib—kidney cancer	0.000171	0.000555	CcSEcCtD
Niacin—Vomiting—Everolimus—kidney cancer	0.00017	0.000553	CcSEcCtD
Niacin—Paraesthesia—Vincristine—kidney cancer	0.00017	0.000552	CcSEcCtD
Niacin—Dermatitis bullous—Doxorubicin—kidney cancer	0.000169	0.000549	CcSEcCtD
Niacin—Rash—Everolimus—kidney cancer	0.000169	0.000548	CcSEcCtD
Niacin—Dermatitis—Everolimus—kidney cancer	0.000168	0.000548	CcSEcCtD
Niacin—Headache—Vinblastine—kidney cancer	0.000168	0.000547	CcSEcCtD
Niacin—Angioedema—Paclitaxel—kidney cancer	0.000168	0.000546	CcSEcCtD
Niacin—Headache—Everolimus—kidney cancer	0.000168	0.000545	CcSEcCtD
Niacin—Hypotension—Gemcitabine—kidney cancer	0.000167	0.000544	CcSEcCtD
Niacin—Abdominal pain—Dactinomycin—kidney cancer	0.000167	0.000543	CcSEcCtD
Niacin—Body temperature increased—Dactinomycin—kidney cancer	0.000167	0.000543	CcSEcCtD
Niacin—Visual impairment—Capecitabine—kidney cancer	0.000167	0.000543	CcSEcCtD
Niacin—Asthenia—Sorafenib—kidney cancer	0.000167	0.000541	CcSEcCtD
Niacin—Vertigo—Paclitaxel—kidney cancer	0.000165	0.000537	CcSEcCtD
Niacin—Syncope—Paclitaxel—kidney cancer	0.000165	0.000536	CcSEcCtD
Niacin—Leukopenia—Paclitaxel—kidney cancer	0.000165	0.000535	CcSEcCtD
Niacin—Hypersensitivity—Sunitinib—kidney cancer	0.000165	0.000535	CcSEcCtD
Niacin—Decreased appetite—Vincristine—kidney cancer	0.000164	0.000534	CcSEcCtD
Niacin—Pruritus—Sorafenib—kidney cancer	0.000164	0.000534	CcSEcCtD
Niacin—Vomiting—Erlotinib—kidney cancer	0.000164	0.000533	CcSEcCtD
Niacin—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000163	0.000531	CcSEcCtD
Niacin—Gastrointestinal disorder—Vincristine—kidney cancer	0.000163	0.00053	CcSEcCtD
Niacin—Rash—Erlotinib—kidney cancer	0.000163	0.000529	CcSEcCtD
Niacin—Dermatitis—Erlotinib—kidney cancer	0.000163	0.000528	CcSEcCtD
Niacin—Palpitations—Paclitaxel—kidney cancer	0.000162	0.000528	CcSEcCtD
Niacin—Insomnia—Gemcitabine—kidney cancer	0.000162	0.000527	CcSEcCtD
Niacin—Eye disorder—Capecitabine—kidney cancer	0.000162	0.000527	CcSEcCtD
Niacin—Headache—Erlotinib—kidney cancer	0.000162	0.000526	CcSEcCtD
Niacin—Tinnitus—Capecitabine—kidney cancer	0.000162	0.000525	CcSEcCtD
Niacin—Loss of consciousness—Paclitaxel—kidney cancer	0.000162	0.000525	CcSEcCtD
Niacin—Pain—Vincristine—kidney cancer	0.000162	0.000525	CcSEcCtD
Niacin—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000162	0.000525	CcSEcCtD
Niacin—Paraesthesia—Gemcitabine—kidney cancer	0.000161	0.000523	CcSEcCtD
Niacin—Flushing—Capecitabine—kidney cancer	0.000161	0.000523	CcSEcCtD
Niacin—Cough—Paclitaxel—kidney cancer	0.00016	0.000522	CcSEcCtD
Niacin—Asthenia—Sunitinib—kidney cancer	0.00016	0.000521	CcSEcCtD
Niacin—Dyspnoea—Gemcitabine—kidney cancer	0.00016	0.000519	CcSEcCtD
Niacin—Nausea—Vinblastine—kidney cancer	0.000159	0.000518	CcSEcCtD
Niacin—Somnolence—Gemcitabine—kidney cancer	0.000159	0.000518	CcSEcCtD
Niacin—Migraine—Doxorubicin—kidney cancer	0.000159	0.000517	CcSEcCtD
Niacin—Nausea—Everolimus—kidney cancer	0.000159	0.000516	CcSEcCtD
Niacin—Diarrhoea—Sorafenib—kidney cancer	0.000159	0.000516	CcSEcCtD
Niacin—Pruritus—Sunitinib—kidney cancer	0.000158	0.000514	CcSEcCtD
Niacin—Angiopathy—Capecitabine—kidney cancer	0.000157	0.000511	CcSEcCtD
Niacin—Arthralgia—Paclitaxel—kidney cancer	0.000157	0.000509	CcSEcCtD
Niacin—Myalgia—Paclitaxel—kidney cancer	0.000157	0.000509	CcSEcCtD
Niacin—Face oedema—Doxorubicin—kidney cancer	0.000156	0.000507	CcSEcCtD
Niacin—Decreased appetite—Gemcitabine—kidney cancer	0.000156	0.000507	CcSEcCtD
Niacin—Hypersensitivity—Dactinomycin—kidney cancer	0.000156	0.000506	CcSEcCtD
Niacin—Chills—Capecitabine—kidney cancer	0.000156	0.000506	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000155	0.000505	CcSEcCtD
Niacin—Arrhythmia—Capecitabine—kidney cancer	0.000155	0.000503	CcSEcCtD
Niacin—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000155	0.000503	CcSEcCtD
Niacin—Gastrointestinal pain—Vincristine—kidney cancer	0.000154	0.000502	CcSEcCtD
Niacin—Dizziness—Sorafenib—kidney cancer	0.000154	0.000499	CcSEcCtD
Niacin—Pain—Gemcitabine—kidney cancer	0.000153	0.000498	CcSEcCtD
Niacin—Nausea—Erlotinib—kidney cancer	0.000153	0.000498	CcSEcCtD
Niacin—Alopecia—Capecitabine—kidney cancer	0.000153	0.000498	CcSEcCtD
Niacin—Dry mouth—Paclitaxel—kidney cancer	0.000153	0.000498	CcSEcCtD
Niacin—Diarrhoea—Sunitinib—kidney cancer	0.000153	0.000497	CcSEcCtD
Niacin—Asthenia—Dactinomycin—kidney cancer	0.000152	0.000493	CcSEcCtD
Niacin—Erythema—Capecitabine—kidney cancer	0.000151	0.000491	CcSEcCtD
Niacin—Malnutrition—Capecitabine—kidney cancer	0.000151	0.000491	CcSEcCtD
Niacin—Anaphylactic shock—Paclitaxel—kidney cancer	0.00015	0.000488	CcSEcCtD
Niacin—Oedema—Paclitaxel—kidney cancer	0.00015	0.000488	CcSEcCtD
Niacin—Abdominal pain—Vincristine—kidney cancer	0.000149	0.000486	CcSEcCtD
Niacin—Body temperature increased—Vincristine—kidney cancer	0.000149	0.000486	CcSEcCtD
Niacin—Liver function test abnormal—Doxorubicin—kidney cancer	0.000149	0.000485	CcSEcCtD
Niacin—Flatulence—Capecitabine—kidney cancer	0.000149	0.000483	CcSEcCtD
Niacin—Dry skin—Doxorubicin—kidney cancer	0.000148	0.000481	CcSEcCtD
Niacin—Dizziness—Sunitinib—kidney cancer	0.000148	0.00048	CcSEcCtD
Niacin—Shock—Paclitaxel—kidney cancer	0.000148	0.00048	CcSEcCtD
Niacin—Vomiting—Sorafenib—kidney cancer	0.000148	0.00048	CcSEcCtD
Niacin—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000148	0.00048	CcSEcCtD
Niacin—Tachycardia—Paclitaxel—kidney cancer	0.000146	0.000476	CcSEcCtD
Niacin—Rash—Sorafenib—kidney cancer	0.000146	0.000476	CcSEcCtD
Niacin—Dermatitis—Sorafenib—kidney cancer	0.000146	0.000475	CcSEcCtD
Niacin—Skin disorder—Paclitaxel—kidney cancer	0.000146	0.000474	CcSEcCtD
Niacin—Headache—Sorafenib—kidney cancer	0.000145	0.000473	CcSEcCtD
Niacin—Muscle spasms—Capecitabine—kidney cancer	0.000145	0.000472	CcSEcCtD
Niacin—Hyperhidrosis—Paclitaxel—kidney cancer	0.000145	0.000472	CcSEcCtD
Niacin—Diarrhoea—Dactinomycin—kidney cancer	0.000145	0.00047	CcSEcCtD
Niacin—Anorexia—Paclitaxel—kidney cancer	0.000143	0.000465	CcSEcCtD
Niacin—Muscular weakness—Doxorubicin—kidney cancer	0.000142	0.000463	CcSEcCtD
Niacin—Vision blurred—Capecitabine—kidney cancer	0.000142	0.000462	CcSEcCtD
Niacin—Vomiting—Sunitinib—kidney cancer	0.000142	0.000462	CcSEcCtD
Niacin—Body temperature increased—Gemcitabine—kidney cancer	0.000142	0.000461	CcSEcCtD
Niacin—Rash—Sunitinib—kidney cancer	0.000141	0.000458	CcSEcCtD
Niacin—Dermatitis—Sunitinib—kidney cancer	0.000141	0.000457	CcSEcCtD
Niacin—Abdominal distension—Doxorubicin—kidney cancer	0.000141	0.000457	CcSEcCtD
Niacin—Hypotension—Paclitaxel—kidney cancer	0.00014	0.000456	CcSEcCtD
Niacin—Headache—Sunitinib—kidney cancer	0.00014	0.000455	CcSEcCtD
Niacin—Dysphagia—Doxorubicin—kidney cancer	0.00014	0.000454	CcSEcCtD
Niacin—Influenza—Doxorubicin—kidney cancer	0.00014	0.000454	CcSEcCtD
Niacin—Hypersensitivity—Vincristine—kidney cancer	0.000139	0.000453	CcSEcCtD
Niacin—Nausea—Sorafenib—kidney cancer	0.000138	0.000448	CcSEcCtD
Niacin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000137	0.000444	CcSEcCtD
Niacin—Angina pectoris—Doxorubicin—kidney cancer	0.000136	0.000442	CcSEcCtD
Niacin—Insomnia—Paclitaxel—kidney cancer	0.000136	0.000441	CcSEcCtD
Niacin—Vertigo—Capecitabine—kidney cancer	0.000136	0.000441	CcSEcCtD
Niacin—Asthenia—Vincristine—kidney cancer	0.000136	0.000441	CcSEcCtD
Niacin—Syncope—Capecitabine—kidney cancer	0.000135	0.00044	CcSEcCtD
Niacin—Leukopenia—Capecitabine—kidney cancer	0.000135	0.000439	CcSEcCtD
Niacin—Paraesthesia—Paclitaxel—kidney cancer	0.000135	0.000438	CcSEcCtD
Niacin—Vomiting—Dactinomycin—kidney cancer	0.000134	0.000437	CcSEcCtD
Niacin—Bronchitis—Doxorubicin—kidney cancer	0.000134	0.000436	CcSEcCtD
Niacin—Dyspnoea—Paclitaxel—kidney cancer	0.000134	0.000435	CcSEcCtD
Niacin—Somnolence—Paclitaxel—kidney cancer	0.000133	0.000434	CcSEcCtD
Niacin—Palpitations—Capecitabine—kidney cancer	0.000133	0.000433	CcSEcCtD
Niacin—Rash—Dactinomycin—kidney cancer	0.000133	0.000433	CcSEcCtD
Niacin—Nausea—Sunitinib—kidney cancer	0.000133	0.000431	CcSEcCtD
Niacin—Loss of consciousness—Capecitabine—kidney cancer	0.000133	0.000431	CcSEcCtD
Niacin—Dyspepsia—Paclitaxel—kidney cancer	0.000132	0.000429	CcSEcCtD
Niacin—Cough—Capecitabine—kidney cancer	0.000132	0.000428	CcSEcCtD
Niacin—Decreased appetite—Paclitaxel—kidney cancer	0.00013	0.000424	CcSEcCtD
Niacin—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.00013	0.000421	CcSEcCtD
Niacin—Diarrhoea—Vincristine—kidney cancer	0.000129	0.00042	CcSEcCtD
Niacin—Asthenia—Gemcitabine—kidney cancer	0.000129	0.000418	CcSEcCtD
Niacin—Myalgia—Capecitabine—kidney cancer	0.000128	0.000418	CcSEcCtD
Niacin—Arthralgia—Capecitabine—kidney cancer	0.000128	0.000418	CcSEcCtD
Niacin—Pain—Paclitaxel—kidney cancer	0.000128	0.000417	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000128	0.000415	CcSEcCtD
Niacin—Pruritus—Gemcitabine—kidney cancer	0.000127	0.000412	CcSEcCtD
Niacin—Dry mouth—Capecitabine—kidney cancer	0.000126	0.000408	CcSEcCtD
Niacin—Nausea—Dactinomycin—kidney cancer	0.000126	0.000408	CcSEcCtD
Niacin—Dizziness—Vincristine—kidney cancer	0.000125	0.000406	CcSEcCtD
Niacin—Oedema—Capecitabine—kidney cancer	0.000123	0.0004	CcSEcCtD
Niacin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000123	0.000399	CcSEcCtD
Niacin—Diarrhoea—Gemcitabine—kidney cancer	0.000123	0.000399	CcSEcCtD
Niacin—Stomatitis—Doxorubicin—kidney cancer	0.000121	0.000394	CcSEcCtD
Niacin—Jaundice—Doxorubicin—kidney cancer	0.000121	0.000394	CcSEcCtD
Niacin—Shock—Capecitabine—kidney cancer	0.000121	0.000394	CcSEcCtD
Niacin—Tachycardia—Capecitabine—kidney cancer	0.00012	0.000391	CcSEcCtD
Niacin—Vomiting—Vincristine—kidney cancer	0.00012	0.000391	CcSEcCtD
Niacin—Skin disorder—Capecitabine—kidney cancer	0.00012	0.000389	CcSEcCtD
Niacin—Sweating—Doxorubicin—kidney cancer	0.000119	0.000388	CcSEcCtD
Niacin—Urticaria—Paclitaxel—kidney cancer	0.000119	0.000388	CcSEcCtD
Niacin—Rash—Vincristine—kidney cancer	0.000119	0.000387	CcSEcCtD
Niacin—Hyperhidrosis—Capecitabine—kidney cancer	0.000119	0.000387	CcSEcCtD
Niacin—Dermatitis—Vincristine—kidney cancer	0.000119	0.000387	CcSEcCtD
Niacin—Abdominal pain—Paclitaxel—kidney cancer	0.000119	0.000386	CcSEcCtD
Niacin—Body temperature increased—Paclitaxel—kidney cancer	0.000119	0.000386	CcSEcCtD
Niacin—Headache—Vincristine—kidney cancer	0.000118	0.000385	CcSEcCtD
Niacin—Anorexia—Capecitabine—kidney cancer	0.000117	0.000382	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—FLT1—kidney cancer	0.000117	0.000695	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PDHB—kidney cancer	0.000117	0.000692	CbGpPWpGaD
Niacin—NNMT—Metabolism—GSTP1—kidney cancer	0.000116	0.000689	CbGpPWpGaD
Niacin—QPRT—Disease—HIF1A—kidney cancer	0.000116	0.000685	CbGpPWpGaD
Niacin—QPRT—Disease—TSC2—kidney cancer	0.000115	0.000683	CbGpPWpGaD
Niacin—Hypotension—Capecitabine—kidney cancer	0.000115	0.000374	CcSEcCtD
Niacin—QPRT—Metabolism—GSTM1—kidney cancer	0.000115	0.000681	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TSC1—kidney cancer	0.000115	0.00068	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PSMD7—kidney cancer	0.000115	0.00068	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—ANXA1—kidney cancer	0.000115	0.00068	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000115	0.00068	CbGpPWpGaD
Niacin—Vomiting—Gemcitabine—kidney cancer	0.000114	0.00037	CcSEcCtD
Niacin—SLC16A3—Metabolism—CA9—kidney cancer	0.000114	0.000673	CbGpPWpGaD
Niacin—Rash—Gemcitabine—kidney cancer	0.000113	0.000367	CcSEcCtD
Niacin—Dermatitis—Gemcitabine—kidney cancer	0.000113	0.000367	CcSEcCtD
Niacin—Haemoglobin—Doxorubicin—kidney cancer	0.000112	0.000365	CcSEcCtD
Niacin—Headache—Gemcitabine—kidney cancer	0.000112	0.000365	CcSEcCtD
Niacin—Nausea—Vincristine—kidney cancer	0.000112	0.000365	CcSEcCtD
Niacin—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000112	0.000365	CcSEcCtD
Niacin—Rhinitis—Doxorubicin—kidney cancer	0.000112	0.000364	CcSEcCtD
Niacin—Hepatitis—Doxorubicin—kidney cancer	0.000112	0.000363	CcSEcCtD
Niacin—Haemorrhage—Doxorubicin—kidney cancer	0.000112	0.000363	CcSEcCtD
Niacin—Insomnia—Capecitabine—kidney cancer	0.000111	0.000362	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—FLT1—kidney cancer	0.000111	0.000659	CbGpPWpGaD
Niacin—Hypoaesthesia—Doxorubicin—kidney cancer	0.000111	0.000361	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—POMC—kidney cancer	0.000111	0.000655	CbGpPWpGaD
Niacin—Paraesthesia—Capecitabine—kidney cancer	0.000111	0.000359	CcSEcCtD
Niacin—Hypersensitivity—Paclitaxel—kidney cancer	0.000111	0.000359	CcSEcCtD
Niacin—Oedema peripheral—Doxorubicin—kidney cancer	0.00011	0.000358	CcSEcCtD
Niacin—NNMT—Metabolism—ABCB1—kidney cancer	0.00011	0.000652	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CCBL1—kidney cancer	0.00011	0.00065	CbGpPWpGaD
Niacin—Dyspnoea—Capecitabine—kidney cancer	0.00011	0.000357	CcSEcCtD
Niacin—QPRT—Metabolism—CYP1A1—kidney cancer	0.000109	0.000645	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—JUNB—kidney cancer	0.000109	0.000644	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PAK1—kidney cancer	0.000109	0.000644	CbGpPWpGaD
Niacin—Dyspepsia—Capecitabine—kidney cancer	0.000108	0.000352	CcSEcCtD
Niacin—Visual impairment—Doxorubicin—kidney cancer	0.000108	0.00035	CcSEcCtD
Niacin—Asthenia—Paclitaxel—kidney cancer	0.000108	0.00035	CcSEcCtD
Niacin—Decreased appetite—Capecitabine—kidney cancer	0.000107	0.000348	CcSEcCtD
Niacin—NNMT—Metabolism—GSTM1—kidney cancer	0.000107	0.000633	CbGpPWpGaD
Niacin—Nausea—Gemcitabine—kidney cancer	0.000106	0.000346	CcSEcCtD
Niacin—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000106	0.000346	CcSEcCtD
Niacin—Pruritus—Paclitaxel—kidney cancer	0.000106	0.000345	CcSEcCtD
Niacin—Pain—Capecitabine—kidney cancer	0.000105	0.000342	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—POMC—kidney cancer	0.000105	0.000621	CbGpPWpGaD
Niacin—Eye disorder—Doxorubicin—kidney cancer	0.000104	0.000339	CcSEcCtD
Niacin—Tinnitus—Doxorubicin—kidney cancer	0.000104	0.000339	CcSEcCtD
Niacin—Flushing—Doxorubicin—kidney cancer	0.000104	0.000337	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—JUNB—kidney cancer	0.000103	0.000611	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PAK1—kidney cancer	0.000103	0.000611	CbGpPWpGaD
Niacin—Diarrhoea—Paclitaxel—kidney cancer	0.000103	0.000334	CcSEcCtD
Niacin—QPRT—Disease—APC—kidney cancer	0.000102	0.000603	CbGpPWpGaD
Niacin—QPRT—Disease—KIT—kidney cancer	0.000102	0.000603	CbGpPWpGaD
Niacin—Angiopathy—Doxorubicin—kidney cancer	0.000101	0.00033	CcSEcCtD
Niacin—NNMT—Metabolism—CYP1A1—kidney cancer	0.000101	0.0006	CbGpPWpGaD
Niacin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000101	0.000598	CbGpPWpGaD
Niacin—Gastrointestinal pain—Capecitabine—kidney cancer	0.000101	0.000327	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—POMC—kidney cancer	0.0001	0.000595	CbGpPWpGaD
Niacin—Chills—Doxorubicin—kidney cancer	0.0001	0.000326	CcSEcCtD
Niacin—Arrhythmia—Doxorubicin—kidney cancer	9.98e-05	0.000324	CcSEcCtD
Niacin—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	9.97e-05	0.00059	CbGpPWpGaD
Niacin—Dizziness—Paclitaxel—kidney cancer	9.92e-05	0.000323	CcSEcCtD
Niacin—Alopecia—Doxorubicin—kidney cancer	9.87e-05	0.000321	CcSEcCtD
Niacin—Urticaria—Capecitabine—kidney cancer	9.78e-05	0.000318	CcSEcCtD
Niacin—Body temperature increased—Capecitabine—kidney cancer	9.73e-05	0.000316	CcSEcCtD
Niacin—Abdominal pain—Capecitabine—kidney cancer	9.73e-05	0.000316	CcSEcCtD
Niacin—Malnutrition—Doxorubicin—kidney cancer	9.73e-05	0.000316	CcSEcCtD
Niacin—Erythema—Doxorubicin—kidney cancer	9.73e-05	0.000316	CcSEcCtD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—KRAS—kidney cancer	9.68e-05	0.000573	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CRABP1—kidney cancer	9.66e-05	0.000572	CbGpPWpGaD
Niacin—Flatulence—Doxorubicin—kidney cancer	9.58e-05	0.000312	CcSEcCtD
Niacin—QPRT—Disease—BRAF—kidney cancer	9.58e-05	0.000567	CbGpPWpGaD
Niacin—Tension—Doxorubicin—kidney cancer	9.54e-05	0.00031	CcSEcCtD
Niacin—Vomiting—Paclitaxel—kidney cancer	9.54e-05	0.00031	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—POMC—kidney cancer	9.53e-05	0.000564	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PPAT—kidney cancer	9.52e-05	0.000564	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GLIPR1—kidney cancer	9.52e-05	0.000564	CbGpPWpGaD
Niacin—Rash—Paclitaxel—kidney cancer	9.46e-05	0.000308	CcSEcCtD
Niacin—Dermatitis—Paclitaxel—kidney cancer	9.45e-05	0.000307	CcSEcCtD
Niacin—Nervousness—Doxorubicin—kidney cancer	9.45e-05	0.000307	CcSEcCtD
Niacin—Headache—Paclitaxel—kidney cancer	9.4e-05	0.000306	CcSEcCtD
Niacin—Muscle spasms—Doxorubicin—kidney cancer	9.35e-05	0.000304	CcSEcCtD
Niacin—Vision blurred—Doxorubicin—kidney cancer	9.17e-05	0.000298	CcSEcCtD
Niacin—SLCO2B1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	9.15e-05	0.000542	CbGpPWpGaD
Niacin—Hypersensitivity—Capecitabine—kidney cancer	9.07e-05	0.000295	CcSEcCtD
Niacin—SLC16A3—Metabolism—ITPR2—kidney cancer	8.98e-05	0.000532	CbGpPWpGaD
Niacin—Nausea—Paclitaxel—kidney cancer	8.91e-05	0.00029	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—IGF2—kidney cancer	8.89e-05	0.000527	CbGpPWpGaD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—PIK3CA—kidney cancer	8.89e-05	0.000526	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CDKN2B—kidney cancer	8.85e-05	0.000524	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—APRT—kidney cancer	8.85e-05	0.000524	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—FH—kidney cancer	8.85e-05	0.000524	CbGpPWpGaD
Niacin—Asthenia—Capecitabine—kidney cancer	8.84e-05	0.000287	CcSEcCtD
Niacin—SLCO2B1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	8.83e-05	0.000523	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IFNA1—kidney cancer	8.78e-05	0.00052	CbGpPWpGaD
Niacin—Vertigo—Doxorubicin—kidney cancer	8.74e-05	0.000284	CcSEcCtD
Niacin—Syncope—Doxorubicin—kidney cancer	8.72e-05	0.000284	CcSEcCtD
Niacin—Pruritus—Capecitabine—kidney cancer	8.71e-05	0.000283	CcSEcCtD
Niacin—Leukopenia—Doxorubicin—kidney cancer	8.71e-05	0.000283	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—IGF1R—kidney cancer	8.6e-05	0.000509	CbGpPWpGaD
Niacin—Palpitations—Doxorubicin—kidney cancer	8.59e-05	0.000279	CcSEcCtD
Niacin—Loss of consciousness—Doxorubicin—kidney cancer	8.55e-05	0.000278	CcSEcCtD
Niacin—Cough—Doxorubicin—kidney cancer	8.49e-05	0.000276	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—IGF2—kidney cancer	8.43e-05	0.000499	CbGpPWpGaD
Niacin—Diarrhoea—Capecitabine—kidney cancer	8.43e-05	0.000274	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—CDKN2B—kidney cancer	8.39e-05	0.000497	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GPC3—kidney cancer	8.32e-05	0.000493	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—RAF1—kidney cancer	8.29e-05	0.000491	CbGpPWpGaD
Niacin—Myalgia—Doxorubicin—kidney cancer	8.28e-05	0.000269	CcSEcCtD
Niacin—Arthralgia—Doxorubicin—kidney cancer	8.28e-05	0.000269	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	8.22e-05	0.000267	CcSEcCtD
Niacin—SLC16A3—Metabolism—ACHE—kidney cancer	8.19e-05	0.000485	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GSTT1—kidney cancer	8.19e-05	0.000485	CbGpPWpGaD
Niacin—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	8.19e-05	0.000485	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—IL2—kidney cancer	8.18e-05	0.000485	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IFNA2—kidney cancer	8.17e-05	0.000484	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IGF1R—kidney cancer	8.15e-05	0.000483	CbGpPWpGaD
Niacin—Dizziness—Capecitabine—kidney cancer	8.14e-05	0.000265	CcSEcCtD
Niacin—SLC16A1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	8.13e-05	0.000481	CbGpPWpGaD
Niacin—QPRT—Metabolism—POMC—kidney cancer	8.12e-05	0.000481	CbGpPWpGaD
Niacin—Dry mouth—Doxorubicin—kidney cancer	8.1e-05	0.000263	CcSEcCtD
Niacin—SLC16A1—Metabolism—CA2—kidney cancer	8.1e-05	0.00048	CbGpPWpGaD
Niacin—QPRT—Disease—RAF1—kidney cancer	8e-05	0.000474	CbGpPWpGaD
Niacin—Oedema—Doxorubicin—kidney cancer	7.94e-05	0.000258	CcSEcCtD
Niacin—Anaphylactic shock—Doxorubicin—kidney cancer	7.94e-05	0.000258	CcSEcCtD
Niacin—QPRT—Disease—ERBB2—kidney cancer	7.91e-05	0.000469	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ALAD—kidney cancer	7.89e-05	0.000467	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—RAF1—kidney cancer	7.85e-05	0.000465	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	7.85e-05	0.000465	CbGpPWpGaD
Niacin—Vomiting—Capecitabine—kidney cancer	7.83e-05	0.000255	CcSEcCtD
Niacin—Shock—Doxorubicin—kidney cancer	7.81e-05	0.000254	CcSEcCtD
Niacin—QPRT—Disease—MTOR—kidney cancer	7.81e-05	0.000462	CbGpPWpGaD
Niacin—QPRT—Disease—CD4—kidney cancer	7.79e-05	0.000462	CbGpPWpGaD
Niacin—Rash—Capecitabine—kidney cancer	7.76e-05	0.000252	CcSEcCtD
Niacin—Dermatitis—Capecitabine—kidney cancer	7.76e-05	0.000252	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—IL2—kidney cancer	7.76e-05	0.000459	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—SCARB1—kidney cancer	7.75e-05	0.000459	CbGpPWpGaD
Niacin—Tachycardia—Doxorubicin—kidney cancer	7.75e-05	0.000252	CcSEcCtD
Niacin—QPRT—Disease—PTGS2—kidney cancer	7.74e-05	0.000458	CbGpPWpGaD
Niacin—Headache—Capecitabine—kidney cancer	7.71e-05	0.000251	CcSEcCtD
Niacin—Skin disorder—Doxorubicin—kidney cancer	7.71e-05	0.000251	CcSEcCtD
Niacin—SLC16A1—Metabolism—ST3GAL2—kidney cancer	7.7e-05	0.000456	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTGS1—kidney cancer	7.68e-05	0.000455	CbGpPWpGaD
Niacin—Hyperhidrosis—Doxorubicin—kidney cancer	7.67e-05	0.000249	CcSEcCtD
Niacin—Anorexia—Doxorubicin—kidney cancer	7.57e-05	0.000246	CcSEcCtD
Niacin—NNMT—Metabolism—POMC—kidney cancer	7.55e-05	0.000447	CbGpPWpGaD
Niacin—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	7.53e-05	0.000446	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ALDH1A1—kidney cancer	7.53e-05	0.000446	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PSMD7—kidney cancer	7.53e-05	0.000446	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—RAF1—kidney cancer	7.5e-05	0.000444	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—IL2—kidney cancer	7.43e-05	0.00044	CbGpPWpGaD
Niacin—Hypotension—Doxorubicin—kidney cancer	7.42e-05	0.000241	CcSEcCtD
Niacin—SLC16A1—Hemostasis—IGF2—kidney cancer	7.36e-05	0.000436	CbGpPWpGaD
Niacin—QPRT—Disease—CDKN1B—kidney cancer	7.33e-05	0.000434	CbGpPWpGaD
Niacin—Nausea—Capecitabine—kidney cancer	7.31e-05	0.000238	CcSEcCtD
Niacin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	7.23e-05	0.000235	CcSEcCtD
Niacin—SLC16A1—Metabolism—SLC5A3—kidney cancer	7.22e-05	0.000427	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PGK1—kidney cancer	7.22e-05	0.000427	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—GSTT1—kidney cancer	7.2e-05	0.000427	CbGpPWpGaD
Niacin—Insomnia—Doxorubicin—kidney cancer	7.18e-05	0.000233	CcSEcCtD
Niacin—SLC16A3—Metabolism—BCHE—kidney cancer	7.14e-05	0.000423	CbGpPWpGaD
Niacin—Paraesthesia—Doxorubicin—kidney cancer	7.13e-05	0.000232	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—HIF1A—kidney cancer	7.08e-05	0.000419	CbGpPWpGaD
Niacin—Dyspnoea—Doxorubicin—kidney cancer	7.08e-05	0.00023	CcSEcCtD
Niacin—SLC16A1—Metabolism—LDHB—kidney cancer	7.08e-05	0.000419	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TSC2—kidney cancer	7.06e-05	0.000418	CbGpPWpGaD
Niacin—Somnolence—Doxorubicin—kidney cancer	7.06e-05	0.000229	CcSEcCtD
Niacin—SLC16A3—Metabolism—SLC5A5—kidney cancer	7.05e-05	0.000417	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—IL2—kidney cancer	7.04e-05	0.000417	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—SLC5A5—kidney cancer	6.99e-05	0.000414	CbGpPWpGaD
Niacin—Dyspepsia—Doxorubicin—kidney cancer	6.99e-05	0.000227	CcSEcCtD
Niacin—SLCO2B1—Transmembrane transport of small molecules—ABCB1—kidney cancer	6.97e-05	0.000413	CbGpPWpGaD
Niacin—QPRT—Disease—CTNNB1—kidney cancer	6.92e-05	0.00041	CbGpPWpGaD
Niacin—Decreased appetite—Doxorubicin—kidney cancer	6.9e-05	0.000224	CcSEcCtD
Niacin—Gastrointestinal disorder—Doxorubicin—kidney cancer	6.85e-05	0.000223	CcSEcCtD
Niacin—SLC16A3—Metabolism—SLC2A1—kidney cancer	6.81e-05	0.000403	CbGpPWpGaD
Niacin—Pain—Doxorubicin—kidney cancer	6.79e-05	0.000221	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—KDR—kidney cancer	6.77e-05	0.000401	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—PTGS1—kidney cancer	6.75e-05	0.0004	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—SLC2A1—kidney cancer	6.75e-05	0.0004	CbGpPWpGaD
Niacin—QPRT—Disease—PTEN—kidney cancer	6.75e-05	0.0004	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—IL2—kidney cancer	6.72e-05	0.000398	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—HIF1A—kidney cancer	6.71e-05	0.000397	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TSC2—kidney cancer	6.69e-05	0.000396	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—RAF1—kidney cancer	6.49e-05	0.000384	CbGpPWpGaD
Niacin—Gastrointestinal pain—Doxorubicin—kidney cancer	6.49e-05	0.000211	CcSEcCtD
Niacin—QPRT—Metabolism—PTGS2—kidney cancer	6.48e-05	0.000384	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—KDR—kidney cancer	6.42e-05	0.00038	CbGpPWpGaD
Niacin—Urticaria—Doxorubicin—kidney cancer	6.31e-05	0.000205	CcSEcCtD
Niacin—Body temperature increased—Doxorubicin—kidney cancer	6.27e-05	0.000204	CcSEcCtD
Niacin—Abdominal pain—Doxorubicin—kidney cancer	6.27e-05	0.000204	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—KIT—kidney cancer	6.24e-05	0.000369	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—APC—kidney cancer	6.24e-05	0.000369	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	6.2e-05	0.000367	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CA9—kidney cancer	6.14e-05	0.000363	CbGpPWpGaD
Niacin—CYP2D6—Phase 1 - Functionalization of compounds—POMC—kidney cancer	6.11e-05	0.000362	CbGpPWpGaD
Niacin—NNMT—Metabolism—PTGS2—kidney cancer	6.02e-05	0.000357	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—MAPK3—kidney cancer	5.97e-05	0.000354	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—POMC—kidney cancer	5.94e-05	0.000352	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—APC—kidney cancer	5.91e-05	0.00035	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—KIT—kidney cancer	5.91e-05	0.00035	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—BRAF—kidney cancer	5.86e-05	0.000347	CbGpPWpGaD
Niacin—Hypersensitivity—Doxorubicin—kidney cancer	5.85e-05	0.00019	CcSEcCtD
Niacin—QPRT—Disease—MAPK3—kidney cancer	5.76e-05	0.000341	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—VEGFA—kidney cancer	5.71e-05	0.000338	CbGpPWpGaD
Niacin—Asthenia—Doxorubicin—kidney cancer	5.7e-05	0.000185	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—MAPK1—kidney cancer	5.68e-05	0.000337	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GSTP1—kidney cancer	5.68e-05	0.000336	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—MAPK3—kidney cancer	5.66e-05	0.000335	CbGpPWpGaD
Niacin—QPRT—Metabolism—PTEN—kidney cancer	5.65e-05	0.000335	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—POMC—kidney cancer	5.63e-05	0.000333	CbGpPWpGaD
Niacin—Pruritus—Doxorubicin—kidney cancer	5.62e-05	0.000183	CcSEcCtD
Niacin—QPRT—Disease—MYC—kidney cancer	5.61e-05	0.000332	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—BRAF—kidney cancer	5.56e-05	0.000329	CbGpPWpGaD
Niacin—QPRT—Disease—MAPK1—kidney cancer	5.48e-05	0.000325	CbGpPWpGaD
Niacin—Diarrhoea—Doxorubicin—kidney cancer	5.43e-05	0.000177	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—PIK3CA—kidney cancer	5.43e-05	0.000322	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—MAPK3—kidney cancer	5.41e-05	0.00032	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—MAPK1—kidney cancer	5.39e-05	0.000319	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ABCB1—kidney cancer	5.37e-05	0.000318	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—KRAS—kidney cancer	5.37e-05	0.000318	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—ABCB1—kidney cancer	5.33e-05	0.000316	CbGpPWpGaD
Niacin—NNMT—Metabolism—PTEN—kidney cancer	5.25e-05	0.000311	CbGpPWpGaD
Niacin—Dizziness—Doxorubicin—kidney cancer	5.25e-05	0.000171	CcSEcCtD
Niacin—SLC16A1—Metabolism—CRABP1—kidney cancer	5.22e-05	0.000309	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GSTM1—kidney cancer	5.22e-05	0.000309	CbGpPWpGaD
Niacin—QPRT—Disease—KRAS—kidney cancer	5.18e-05	0.000307	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—PIK3CA—kidney cancer	5.15e-05	0.000305	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—MAPK1—kidney cancer	5.14e-05	0.000305	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—KRAS—kidney cancer	5.09e-05	0.000301	CbGpPWpGaD
Niacin—Vomiting—Doxorubicin—kidney cancer	5.05e-05	0.000164	CcSEcCtD
Niacin—Rash—Doxorubicin—kidney cancer	5e-05	0.000163	CcSEcCtD
Niacin—Dermatitis—Doxorubicin—kidney cancer	5e-05	0.000163	CcSEcCtD
Niacin—CYP2D6—Biological oxidations—GSTP1—kidney cancer	4.99e-05	0.000296	CbGpPWpGaD
Niacin—Headache—Doxorubicin—kidney cancer	4.97e-05	0.000162	CcSEcCtD
Niacin—SLC16A3—Metabolism—CYP1A1—kidney cancer	4.95e-05	0.000293	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—PIK3CA—kidney cancer	4.93e-05	0.000292	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—GSTP1—kidney cancer	4.93e-05	0.000292	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—RAF1—kidney cancer	4.89e-05	0.00029	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—RELA—kidney cancer	4.87e-05	0.000289	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—KRAS—kidney cancer	4.86e-05	0.000288	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ITPR2—kidney cancer	4.85e-05	0.000287	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—ERBB2—kidney cancer	4.84e-05	0.000287	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MTOR—kidney cancer	4.78e-05	0.000283	CbGpPWpGaD
Niacin—QPRT—Disease—PIK3CA—kidney cancer	4.76e-05	0.000282	CbGpPWpGaD
Niacin—Nausea—Doxorubicin—kidney cancer	4.71e-05	0.000153	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—PIK3CA—kidney cancer	4.67e-05	0.000277	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—RAF1—kidney cancer	4.64e-05	0.000275	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—RELA—kidney cancer	4.62e-05	0.000274	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—ERBB2—kidney cancer	4.59e-05	0.000272	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—GSTM1—kidney cancer	4.59e-05	0.000272	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MTOR—kidney cancer	4.53e-05	0.000268	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—GSTM1—kidney cancer	4.53e-05	0.000268	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CDKN1B—kidney cancer	4.48e-05	0.000266	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—PIK3CA—kidney cancer	4.46e-05	0.000264	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTT1—kidney cancer	4.42e-05	0.000262	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ACHE—kidney cancer	4.42e-05	0.000262	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL2—kidney cancer	4.39e-05	0.00026	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—CYP1A1—kidney cancer	4.35e-05	0.000258	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TP53—kidney cancer	4.32e-05	0.000256	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—CYP1A1—kidney cancer	4.29e-05	0.000254	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CCND1—kidney cancer	4.28e-05	0.000253	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—JUN—kidney cancer	4.27e-05	0.000253	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CDKN1B—kidney cancer	4.25e-05	0.000252	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CTNNB1—kidney cancer	4.24e-05	0.000251	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SCARB1—kidney cancer	4.19e-05	0.000248	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL2—kidney cancer	4.16e-05	0.000246	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTGS1—kidney cancer	4.14e-05	0.000245	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PTEN—kidney cancer	4.13e-05	0.000245	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PSMD7—kidney cancer	4.06e-05	0.000241	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CCND1—kidney cancer	4.06e-05	0.00024	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—RAF1—kidney cancer	4.05e-05	0.00024	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—JUN—kidney cancer	4.05e-05	0.00024	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CTNNB1—kidney cancer	4.02e-05	0.000238	CbGpPWpGaD
Niacin—QPRT—Metabolism—PIK3CA—kidney cancer	3.99e-05	0.000236	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.95e-05	0.000234	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PTEN—kidney cancer	3.91e-05	0.000232	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—BCHE—kidney cancer	3.85e-05	0.000228	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ACY1—kidney cancer	3.83e-05	0.000227	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SLC5A5—kidney cancer	3.81e-05	0.000225	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—VEGFA—kidney cancer	3.73e-05	0.000221	CbGpPWpGaD
Niacin—NNMT—Metabolism—PIK3CA—kidney cancer	3.71e-05	0.000219	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—POMC—kidney cancer	3.69e-05	0.000218	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SLC2A1—kidney cancer	3.68e-05	0.000218	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IL2—kidney cancer	3.63e-05	0.000215	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—VEGFA—kidney cancer	3.54e-05	0.000209	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MAPK3—kidney cancer	3.53e-05	0.000209	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.51e-05	0.000208	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MYC—kidney cancer	3.43e-05	0.000203	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MAPK1—kidney cancer	3.36e-05	0.000199	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MAPK3—kidney cancer	3.34e-05	0.000198	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PDHB—kidney cancer	3.25e-05	0.000193	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MYC—kidney cancer	3.25e-05	0.000193	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—POMC—kidney cancer	3.24e-05	0.000192	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MAPK1—kidney cancer	3.18e-05	0.000188	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—KRAS—kidney cancer	3.17e-05	0.000188	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—VEGFA—kidney cancer	3.09e-05	0.000183	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTP1—kidney cancer	3.07e-05	0.000182	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CCBL1—kidney cancer	3.06e-05	0.000181	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—RAF1—kidney cancer	3.01e-05	0.000179	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—KRAS—kidney cancer	3.01e-05	0.000178	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTGS2—kidney cancer	2.94e-05	0.000174	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—MAPK3—kidney cancer	2.92e-05	0.000173	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CA—kidney cancer	2.91e-05	0.000173	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ABCB1—kidney cancer	2.9e-05	0.000172	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TP53—kidney cancer	2.82e-05	0.000167	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTM1—kidney cancer	2.82e-05	0.000167	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—MAPK1—kidney cancer	2.78e-05	0.000165	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CA—kidney cancer	2.76e-05	0.000164	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TP53—kidney cancer	2.67e-05	0.000158	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP1A1—kidney cancer	2.67e-05	0.000158	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GLIPR1—kidney cancer	2.65e-05	0.000157	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PPAT—kidney cancer	2.65e-05	0.000157	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—KRAS—kidney cancer	2.62e-05	0.000155	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTEN—kidney cancer	2.57e-05	0.000152	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—FH—kidney cancer	2.47e-05	0.000146	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—APRT—kidney cancer	2.47e-05	0.000146	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CA—kidney cancer	2.41e-05	0.000143	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TP53—kidney cancer	2.33e-05	0.000138	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GPC3—kidney cancer	2.32e-05	0.000137	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CA2—kidney cancer	2.26e-05	0.000134	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ALAD—kidney cancer	2.2e-05	0.00013	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ST3GAL2—kidney cancer	2.15e-05	0.000127	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ALDH1A1—kidney cancer	2.1e-05	0.000124	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC5A3—kidney cancer	2.01e-05	0.000119	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PGK1—kidney cancer	2.01e-05	0.000119	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—POMC—kidney cancer	1.99e-05	0.000118	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—LDHB—kidney cancer	1.97e-05	0.000117	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CA—kidney cancer	1.81e-05	0.000107	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CA9—kidney cancer	1.71e-05	0.000101	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTGS2—kidney cancer	1.59e-05	9.41e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CRABP1—kidney cancer	1.45e-05	8.61e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTEN—kidney cancer	1.39e-05	8.2e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ITPR2—kidney cancer	1.35e-05	8e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTT1—kidney cancer	1.23e-05	7.3e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ACHE—kidney cancer	1.23e-05	7.3e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SCARB1—kidney cancer	1.17e-05	6.91e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTGS1—kidney cancer	1.15e-05	6.84e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PSMD7—kidney cancer	1.13e-05	6.71e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—BCHE—kidney cancer	1.07e-05	6.36e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC5A5—kidney cancer	1.06e-05	6.28e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC2A1—kidney cancer	1.02e-05	6.06e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CA—kidney cancer	9.77e-06	5.79e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTP1—kidney cancer	8.54e-06	5.06e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ABCB1—kidney cancer	8.08e-06	4.79e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTM1—kidney cancer	7.85e-06	4.65e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP1A1—kidney cancer	7.44e-06	4.41e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—POMC—kidney cancer	5.55e-06	3.29e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTGS2—kidney cancer	4.42e-06	2.62e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTEN—kidney cancer	3.86e-06	2.29e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CA—kidney cancer	2.72e-06	1.61e-05	CbGpPWpGaD
